Patents by Inventor Jean-François DUBUISSON

Jean-François DUBUISSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS
    Publication number: 20240108594
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Application
    Filed: September 14, 2023
    Publication date: April 4, 2024
    Inventors: Claire Mégret, Hervé Guillard, Jean-François Dubuisson
  • Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
    Patent number: 11896572
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: August 8, 2023
    Date of Patent: February 13, 2024
    Assignee: Flamel Ireland Limited
    Inventors: Jordan Dubow, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
    Patent number: 11839597
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: December 12, 2023
    Assignee: Flamel Ireland Limited
    Inventors: Claire Megret, Herve Guillard, Jean-Francois Dubuisson
  • MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS
    Publication number: 20230381131
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Application
    Filed: August 8, 2023
    Publication date: November 30, 2023
    Inventors: Jordan Dubow, Hervé Guillard, Claire Mégret, Jean-François DUBUISSON
  • Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
    Patent number: 11826335
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: January 12, 2023
    Date of Patent: November 28, 2023
    Assignee: Flamel Ireland Limited
    Inventors: Jordan Dubow, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
    Patent number: 11779557
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: February 7, 2022
    Date of Patent: October 10, 2023
    Assignee: Flamel Ireland Limited
    Inventors: Jordan Dubow, Cendrine Grangeon, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
    Patent number: 11766418
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: December 6, 2022
    Date of Patent: September 26, 2023
    Assignee: Flamel Ireland Limited
    Inventors: Jordan Dubow, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS
    Publication number: 20230210804
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Application
    Filed: March 10, 2023
    Publication date: July 6, 2023
    Inventors: Jordan Dubow, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS
    Publication number: 20230172893
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Application
    Filed: January 12, 2023
    Publication date: June 8, 2023
    Inventors: Jordan DUBOW, Hervé GUILLARD, Claire Mégret, Jean-François DUBUISSON
  • MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS
    Publication number: 20230172892
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Application
    Filed: December 6, 2022
    Publication date: June 8, 2023
    Inventors: Jordan Dubow, Hervé Guillard, Claire Mégret, Jean-François DUBUISSON
  • Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
    Patent number: 11602512
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: October 8, 2021
    Date of Patent: March 14, 2023
    Assignee: Flamel Ireland Limited
    Inventors: Jordan Dubow, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
    Patent number: 11602513
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: October 8, 2021
    Date of Patent: March 14, 2023
    Assignee: Flamel Ireland Limited
    Inventors: Jordan Dubow, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
    Patent number: 11583510
    Abstract: Provided herein are methods of administering a once-nightly dosage of gamma-hydroxybutyrate after a high-fat meal.
    Type: Grant
    Filed: February 7, 2022
    Date of Patent: February 21, 2023
    Assignee: Flamel Ireland Limited
    Inventors: Julien Grassot, David Monteith, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
    Patent number: 11504347
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: October 8, 2021
    Date of Patent: November 22, 2022
    Assignee: Flamel Ireland Limited
    Inventors: Julien Grassot, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS
    Publication number: 20220016066
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Application
    Filed: September 24, 2021
    Publication date: January 20, 2022
    Inventors: Claire Megret, Herve Guillard, Jean-Francois Dubuisson
  • Pharmaceutical oral formulation comprising bacteria
    Patent number: 11141440
    Abstract: The present invention relates to a pharmaceutical oral formulation for use in the administration of at least two bacteria derived from fecal microbiota to mammals for the treatment and/or prevention of dysbiosis and associated pathologies. The pharmaceutical oral formulation is encapsulated mixture of at least two bacteria derived from fecal microbiota wherein the capsules are coated in a pH responsive polymer composition comprising: a. 50-70% poly(methyl acrylate-co-methyl methacrylate-co-methacrylic acid) 7:3:1 by weight of dry polymer, b. 10-30% poly(methacrylic acid-co-ethyl acrylate) 1:1 by weight of dry polymer, c. at least one fatty acid mono-, di- or tri-glyceride ester, or mixtures thereof, d. at least one plasticizer, e. at least one non-ionic emulsifier. The pharmaceutical oral formulation is especially designed to be delivered principally in the ileum and colon and to maintain the sample bacterial viability and diversity.
    Type: Grant
    Filed: November 16, 2018
    Date of Patent: October 12, 2021
    Assignees: MAAT PHARMA, BIOCODEX
    Inventors: Carole Schwintner, Marianne Robin, Jean-François Dubuisson, Hervé Affagard, Cédric Michenet, Amandine Bardy
  • MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS
    Publication number: 20210267928
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Application
    Filed: May 17, 2021
    Publication date: September 2, 2021
    Inventors: Claire Megret, Herve Guillard, Jean-Francois Dubuisson
  • Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
    Patent number: 11065224
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: July 31, 2019
    Date of Patent: July 20, 2021
    Assignee: Flamel Ireland Limited
    Inventors: Claire Megret, Herve Guillard, Jean-Francois Dubuisson
  • Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
    Patent number: 11052061
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: May 22, 2019
    Date of Patent: July 6, 2021
    Assignee: Flamel Ireland Limited
    Inventors: Claire Megret, Herve Guillard, Jean-Francois Dubuisson
  • MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS
    Publication number: 20210186916
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Application
    Filed: March 8, 2021
    Publication date: June 24, 2021
    Inventors: Claire Megret, Herve Guillard, Jean-Francois Dubuisson